1.13 Genome Fingerprinting of a Proliferative B-cell Subset in Chronic Lymphocytic Leukemia

2011 ◽  
Vol 11 ◽  
pp. S149
Author(s):  
P. Oppezzo ◽  
F. Palacios ◽  
C. Abreu ◽  
P. Moreno ◽  
T. Fernández-Calero ◽  
...  
2016 ◽  
Vol 213 (13) ◽  
pp. 3007-3024 ◽  
Author(s):  
Kyoko Hayakawa ◽  
Anthony M. Formica ◽  
Joni Brill-Dashoff ◽  
Susan A. Shinton ◽  
Daiju Ichikawa ◽  
...  

In mice, generation of autoreactive CD5+ B cells occurs as a consequence of BCR signaling induced by (self)-ligand exposure from fetal/neonatal B-1 B cell development. A fraction of these cells self-renew and persist as a minor B1 B cell subset throughout life. Here, we show that transfer of early generated B1 B cells from Eμ-TCL1 transgenic mice resulted in chronic lymphocytic leukemia (CLL) with a biased repertoire, including stereotyped BCRs. Thus, B1 B cells bearing restricted BCRs can become CLL during aging. Increased anti-thymocyte/Thy-1 autoreactive (ATA) BCR cells in the B1 B cell subset by transgenic expression yielded spontaneous ATA B-CLL/lymphoma incidence, enhanced by TCL1 transgenesis. In contrast, ATA B-CLL did not develop from other B cell subsets, even when the identical ATA BCR was expressed on a Thy-1 low/null background. Thus, both a specific BCR and B1 B cell context were important for CLL progression. Neonatal B1 B cells and their CLL progeny in aged mice continued to express moderately up-regulated c-Myc and down-regulated proapoptotic Bmf, unlike most mature B cells in the adult. Thus, there is a genetic predisposition inherent in B-1 development generating restricted BCRs and self-renewal capacity, with both features contributing to potential for progression to CLL.


Leukemia ◽  
2005 ◽  
Vol 19 (12) ◽  
pp. 2339-2341 ◽  
Author(s):  
T Aurran-Schleinitz ◽  
W Telford ◽  
S Perfetto ◽  
N Caporaso ◽  
W Wilson ◽  
...  

1980 ◽  
Vol 152 (1) ◽  
pp. 229-234 ◽  
Author(s):  
L Boumsell ◽  
H Coppin ◽  
D Pham ◽  
B Raynal ◽  
J Lemerle ◽  
...  

We obtained a monoclonal antibody, A50, after immunizing Biozzi's high responder strain of mice with T cell chronic lymphocytic leukemia (T-CLL) cells. A50 recognized an antigen present on the surface of B cell chronic lymphocytic leukemia cells from many patients and from cells of T lineage from any subject we tested. We could not find this antigen either on the surface of normal B cell or on other non-T cell malignancies. On T cells, this antigen was present on a subpopulation of thymus cells, and on most peripheral T cells. The antigen was present on the surface of cells from T-CLL, Sézary's disease, and a subset o T cell lymphoma. The antigen seemed to belong to a complex set of antigenic determinants that we had defined with rabbit antisera.


2012 ◽  
Vol 209 (12) ◽  
pp. 2183-2198 ◽  
Author(s):  
Marc Seifert ◽  
Ludger Sellmann ◽  
Johannes Bloehdorn ◽  
Frederik Wein ◽  
Stephan Stilgenbauer ◽  
...  

The cellular origin of chronic lymphocytic leukemia (CLL) is still debated, although this information is critical to understanding its pathogenesis. Transcriptome analyses of CLL and the main normal B cell subsets from human blood and spleen revealed that immunoglobulin variable region (IgV) gene unmutated CLL derives from unmutated mature CD5+ B cells and mutated CLL derives from a distinct, previously unrecognized CD5+CD27+ post–germinal center B cell subset. Stereotyped V gene rearrangements are enriched among CD5+ B cells, providing independent evidence for a CD5+ B cell derivation of CLL. Notably, these CD5+ B cell populations include oligoclonal expansions already found in young healthy adults, putatively representing an early phase in CLL development before the CLL precursor lesion monoclonal B cell lymphocytosis. Finally, we identified deregulated proteins, including EBF1 and KLF transcription factors, that were not detected in previous comparisons of CLL and conventional B cells.


2021 ◽  
Vol 11 ◽  
Author(s):  
Xun Wu ◽  
J. Ernesto Fajardo-Despaigne ◽  
Christine Zhang ◽  
Vishala Neppalli ◽  
Versha Banerji ◽  
...  

Follicular helper T cells (TFH) have specialized properties in promoting normal B cell activation but their role in chronic lymphocytic leukemia (CLL) is unknown. We find that TFH cells are elevated in CLL patients and are phenotypically abnormal, expressing higher levels of PD-1, TIGIT, CD40L, IFNγ and IL-21, and exhibiting abnormal composition of TFH1, TFH2 and TFH17 subsets. Frequencies of CD4-positive T cells expressing TFH1 markers and IL-21 were positively correlated with patient lymphocyte counts and RAI stage, suggesting that accumulation of abnormal TFH cells is concomitant with expansion of the leukemic B cell clone. Treatment with ibrutinib led to normalization of TFH frequencies and phenotype. TFH cells identified in CLL bone marrow display elevated expression of several functional markers compared to blood TFH cells. CLL T cell-B cell co-culture experiments revealed a correlation of patient TFH frequencies with functional ability of their CD4-positive T cells to promote CLL proliferation. Conversely, CLL cells can preferentially activate the TFH cell subset in co-culture. Together our results indicate that CLL development is associated with expansion of abnormal TFH populations that produce elevated levels of cytokines and costimulatory molecules which may help support CLL proliferation.


1985 ◽  
Vol 28 (9) ◽  
pp. 971-976 ◽  
Author(s):  
C. Plater-Zyberk ◽  
R. N. Maini ◽  
K. Lam ◽  
T. D. Kennedy ◽  
G. Janossy

Blood ◽  
2017 ◽  
Vol 129 (7) ◽  
pp. 866-878 ◽  
Author(s):  
Kristine Niss Arfelt ◽  
Line Barington ◽  
Tau Benned-Jensen ◽  
Valentina Kubale ◽  
Alexander L. Kovalchuk ◽  
...  

Key PointshEBI2 (GPR183) expression in mice leads to an abnormally expanded CD5+ B1a B-cell subset. Mice expressing hEBI2 develop late-onset lymphomas similar to CLL.


2006 ◽  
Vol 12 (4) ◽  
pp. 187-192
Author(s):  
F. Scamardella ◽  
M. Maconi ◽  
L. Albertazzi ◽  
B. Gamberi ◽  
L. Gugliotta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document